PeptidePedia The community reference

Contributions of BlankVialBo

User contributions·49 logged edits·page 1 of 1

Contributions by BlankVialBo, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 288 edits includes activity predating the current log.

  1. 15:05, 26 Jul 2026 (diff | hist) Talk:Asymchem Laboratories 1,244 +213 /* Notability, and the oldest registry record on the wiki */ reply
  2. 11:15, 24 Jun 2026 (diff | hist) Talk:Counterfeit peptide 674 +163 /* Cake appearance as evidence */ new section
  3. 11:35, 16 Jun 2026 (diff | hist) Talk:Underfilling 674 +193 /* Tare error on small fills */ new section
  4. 14:07, 4 Jun 2026 (diff | hist) GenScript Peptides 17,833 ±0 fix a dangling clause
  5. 17:50, 30 May 2026 (diff | hist) Hubei Jianxiang Bioscience 14,855 ±0 correct the other-designations row — those are trading variants, not subsidiaries
  6. 04:10, 28 Mar 2026 (diff | hist) Shanghai ERP Biotechnology 14,637 +220 convert the product range to a table so the documentation column lines up
  7. 13:25, 24 Mar 2026 (diff | hist) Talk:Vial filling and stoppering 611 +115 /* Vacuum check */ reply
  8. 03:50, 4 Mar 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 16,352 +226 m clarify that no manufacturing or marketing authorisation is claimed or established
  9. 07:10, 25 Feb 2026 (diff | hist) SinoPep 18,140 +1,342 state which lines are held in regional stock
  10. 05:59, 18 Feb 2026 (diff | hist) GenScript Peptides 15,685 +433 expand §Distribution and dispatch
  11. 09:48, 7 Feb 2026 (diff | hist) GenScript Peptides 15,252 ±0 m expand §Notability and coverage
  12. 00:06, 26 Jan 2026 (diff | hist) Flourishglobal Peptide Biotech 14,551 +517 m add the note that this wiki publishes no score and no league table
  13. 19:49, 26 Dec 2025 (diff | hist) AmbioPharm 11,309 +512 correct the trading name — the short code and the legal name are different things
  14. 13:50, 25 Dec 2025 (diff | hist) Hunan Aslsen Technology 15,272 ±0 label the reception tally as weak, self-selected evidence at this point of use
  15. 09:59, 12 Dec 2025 (diff | hist) Counterfeit peptide 5,488 ±0 m close an unbalanced quotation mark
  16. 18:49, 26 Oct 2025 (diff | hist) Flourishglobal Peptide Biotech 12,150 +207 add the minimum order quantity for custom synthesis
  17. 08:45, 24 Sep 2025 (diff | hist) Counterfeit peptide 5,229 +303 m clarify that agreement between certificate and report is a weak finding
  18. 06:36, 23 Sep 2025 (diff | hist) Guangzhou JEEP Biotechnology 14,075 +226 m rm the comparison with another supplier; there is no common basis for it
  19. 01:43, 17 Sep 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 7,549 ±0 add the incorporation year, attributed to the registry record
  20. 21:02, 7 Sep 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 13,035 +485 m typo
  21. 23:14, 23 Aug 2025 (diff | hist) Shanghai ERP Biotechnology 5,367 ±0 add the catalogue size and label it self-reported
  22. 19:30, 16 Aug 2025 (diff | hist) GL Biochem (Shanghai) 15,340 +798 m fix hyphenation per PP:MOS
  23. 15:55, 9 Aug 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 5,550 +201 add category for suppliers in China
  24. 09:47, 21 Jul 2025 (diff | hist) High-performance liquid chromatography 6,815 +612 add the cross-link to the compendial chapter
  25. 14:09, 10 Jul 2025 (diff | hist) Guangzhou JEEP Biotechnology 13,051 +810 m rm the adjective — an organisation article describes, it does not praise
  26. 23:05, 3 Jul 2025 (diff | hist) Xi'an Mokemei Biotechnology 7,201 +144 close an unbalanced quotation mark
  27. 08:41, 29 Jun 2025 (diff | hist) WuXi TIDES 13,639 +1,712 split overlong sentence
  28. 02:00, 22 Jun 2025 (diff | hist) Albumin binding half-life extension 6,021 ±0 m fix a broken wikilink
  29. 21:02, 9 Jun 2025 (diff | hist) Wuhan Wansheng Biotechnology 12,233 +902 clarify that a registered business scope is a licensing fact, not a quality assurance
  30. 14:17, 21 May 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 6,235 +2,296 correct the trading name — the short code and the legal name are different things
  31. 12:44, 7 May 2025 (diff | hist) Talk:Shanghai ERP Biotechnology 748 +210 /* Endotoxin results: worth a paragraph? */ reply
  32. 06:10, 25 Apr 2025 (diff | hist) Purity claim inflation 4,595 ±0 m expand §What a purity figure does establish
  33. 05:04, 20 Apr 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 1,937 +1,937 N new article: supplier organisation, created after the notability discussion
  34. 10:40, 11 Apr 2025 (diff | hist) Hubei Jianxiang Bioscience 2,173 +450 add the note that self-published material is usable only for what it states about itself
  35. 15:11, 1 Mar 2025 (diff | hist) Peptide harm reduction 2,785 ±0 move a stray full stop inside the reference
  36. 15:14, 20 Feb 2025 (diff | hist) Solid-phase peptide synthesis 4,279 ±0 attribute the stability figure to the study and its duration
  37. 07:15, 16 Feb 2025 (diff | hist) Qingdao Sigma Chemical 8,841 +1,357 add the reception tally with its period and count stated
  38. 10:01, 5 Feb 2025 (diff | hist) Hunan Aslsen Technology 7,721 +1,429 rm the adjective — an organisation article describes, it does not praise
  39. 09:44, 30 Dec 2024 (diff | hist) Hunan Aslsen Technology 6,012 +599 expand §Corporate identity and history
  40. 13:35, 25 Nov 2024 (diff | hist) Body composition assessment 1,910 ±0 expand §Methods and their precision
  41. 18:18, 17 Oct 2024 (diff | hist) Janoshik Analytical 2,971 ±0 correct the description of the sampling procedure
  42. 17:33, 7 Oct 2024 (diff | hist) VendorInvestigate 2,593 ±0 state the method the reporting service uses, since it is not the only one available
  43. 03:00, 20 Sep 2024 (diff | hist) VendorInvestigate 2,190 ±0 state what the certificate actually carries, field by field
  44. 15:40, 5 Sep 2024 (diff | hist) PeptideMeter 2,054 ±0 rm the aggregate pass-rate figure; the denominator is not knowable
  45. 00:56, 5 Sep 2024 (diff | hist) Wuhan Wansheng Biotechnology 5,202 +885 m add the how-to-request-a-batch-record sentence to §Ordering and availability
  46. 12:43, 16 Aug 2024 (diff | hist) Nantong Guangyuan Chemical 2,793 +38 label the reception tally as weak, self-selected evidence at this point of use
  47. 06:07, 12 Aug 2024 (diff | hist) Guangzhou JEEP Biotechnology 2,965 +212 add the lead time for catalogue lines, as reported
  48. 19:14, 9 Jul 2024 (diff | hist) Wuhan Wansheng Biotechnology 2,861 +1,097 correct the trading name — the short code and the legal name are different things
  49. 22:31, 25 Jun 2024 (diff | hist) Solid-phase peptide synthesis 1,893 +542 m add the excursion tolerance with the study it derives from